{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:08:29Z","timestamp":1791598109699,"version":"4.3.4"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.micpath.2021.104915","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T13:56:58Z","timestamp":1619531818000},"page":"104915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"special_numbering":"C","title":["Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: A comprehensive review"],"prefix":"10.1016","volume":"156","author":[{"given":"Wan-Ting","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En-Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2865-2441","authenticated-orcid":false,"given":"Zhenbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.104915_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.03189","article-title":"Severe pneumonia caused by coinfection with influenza virus followed by methicillin-resistant Staphylococcus aureus induces higher mortality in mice","volume":"9","author":"Jia","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2021.104915_bib2","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s12010-009-8698-5","article-title":"Antibacterial activity of hylomecon hylomeconoides against methicillin-resistant Staphylococcus aureus","volume":"160","author":"Choi","year":"2010","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.micpath.2021.104915_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jgar.2017.09.006","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA) in Iran: a systematic review and meta-analysis","volume":"12","author":"Dadashi","year":"2018","journal-title":"Journal of Global Antimicrobial Resistance"},{"key":"10.1016\/j.micpath.2021.104915_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148437","article-title":"Antibiotic resistance of commensal Staphylococcus aureus and coagulase-negative staphylococci in an international cohort of surgeons: a prospective point-prevalence study","volume":"11","author":"Morgenstern","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104915_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201767","article-title":"Molecular mechanisms of thioridazine resistance in Staphylococcus aureus","volume":"13","author":"Wassmann","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104915_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.micpath.2018.03.014","article-title":"Antibacterial mechanism of artemisinin\/beta-cyclodextrins against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"118","author":"Lin","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2021.104915_bib7","article-title":"Human defensins: a novel approach in the fight against skin colonizing Staphylococcus aureus","volume":"9","author":"Scudiero","year":"2020","journal-title":"Antibiotics-Basel."},{"key":"10.1016\/j.micpath.2021.104915_bib8","article-title":"Regulation of Staphylococcus aureus virulence","volume":"6","author":"Jenul","year":"2018","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.micpath.2021.104915_bib9","article-title":"Resistance of Staphylococcus aureus to antimicrobial agents in Ethiopia: a meta-analysis","volume":"6","author":"Deyno","year":"2017","journal-title":"Antimicrob. Resist. Infect. Contr."},{"key":"10.1016\/j.micpath.2021.104915_bib10","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.3889\/oamjms.2019.871","article-title":"Antibiotic resistance profile and methicillin-resistant encoding genes of Staphylococcus aureus strains isolated from bloodstream infection patients in northern vietnam","volume":"7","author":"Nam","year":"2019","journal-title":"Open access Macedonian journal of medical sciences"},{"key":"10.1016\/j.micpath.2021.104915_bib11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2147\/IDR.S244896","article-title":"Characterization of SCCmec, spa types and multidrug resistant of methicillin-resistant Staphylococcus aureus isolates in ahvaz, Iran","volume":"13","author":"Moosavian","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2021.104915_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.micpath.2016.10.028","article-title":"Staphylococcal chromosomal cassettes mec (SCCmec): a mobile genetic element in methicillin-resistant Staphylococcus aureus","volume":"101","author":"Liu","year":"2016","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2021.104915_bib13","article-title":"SCCmec typing of methicillin-resistant Staphylococcus aureus: an eight year experience","volume":"3","author":"Amirkhiz","year":"2015","journal-title":"Archives of Pediatric Infectious Diseases"},{"key":"10.1016\/j.micpath.2021.104915_bib14","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.44.6.1549-1555.2000","article-title":"A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus","volume":"44","author":"Katayama","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3934\/microbiol.2019.2.117","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: a brief review","volume":"5","author":"Okwu","year":"2019","journal-title":"Aims Microbiology"},{"key":"10.1016\/j.micpath.2021.104915_bib16","first-page":"430","article-title":"Antibiotic resistance in Staphylococcus aureus. Current status and future prospects","volume":"41","author":"Foster","year":"2017","journal-title":"FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Rev."},{"key":"10.1016\/j.micpath.2021.104915_bib17","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s10068-013-0272-9","article-title":"Antibacterial activity of a novel flavonoid, 7-O-butyl naringenin, against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"22","author":"Lee","year":"2013","journal-title":"Food Science and Biotechnology"},{"key":"10.1016\/j.micpath.2021.104915_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000501788","article-title":"Antimicrobial resistance patterns in methicillin-resistant Staphylococcus aureus from patients hospitalized during 2015-2017 in hospitals in Poland","volume":"29","author":"Kot","year":"2020","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.micpath.2021.104915_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.diagmicrobio.2018.09.004","article-title":"Daptomycin for the treatment of Staphylococcus aureus infections complicated by septic pulmonary emboli","volume":"93","author":"Crass","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2021.104915_bib20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s15010-015-0763-0","article-title":"Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature","volume":"43","author":"Baxi","year":"2015","journal-title":"Infection"},{"key":"10.1016\/j.micpath.2021.104915_bib21","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1099\/jmm.0.000566","article-title":"Detection of high levels of resistance to linezolid and vancomycin in Staphylococcus aureus","volume":"66","author":"Azhar","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2021.104915_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.micres.2018.05.002","article-title":"Master mechanisms of Staphylococcus aureus: consider its excellent protective mechanisms hindering vaccine development!","volume":"212","author":"Zhang","year":"2018","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.micpath.2021.104915_bib23","first-page":"5128","article-title":"2010\u5e74\u5ea6\u536b\u751f\u90e8\u5168\u56fd\u7ec6\u83cc\u8010\u836f\u76d1\u6d4b\u62a5\u544a:\u9769\u5170\u9633\u6027\u83cc\u8010\u836f\u76d1\u6d4b","volume":"21","author":"\u90d1\u6ce2","year":"2011","journal-title":"\u4e2d\u534e\u533b\u9662\u611f\u67d3\u5b66\u6742\u5fd7."},{"key":"10.1016\/j.micpath.2021.104915_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy657","article-title":"Current status and trends of antibacterial resistance in China","volume":"67","author":"Hu","year":"2018","journal-title":"Clin. Infect. Dis. : an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.micpath.2021.104915_bib25","first-page":"15","article-title":"\u5168\u56fd\u7ec6\u83cc\u8010\u836f\u76d1\u6d4b\u7f512014\u20142019\u5e74\u7ec6\u83cc\u8010\u836f\u6027\u76d1\u6d4b\u62a5\u544a","volume":"20","year":"2021","journal-title":"\u4e2d\u56fd\u611f\u67d3\u63a7\u5236\u6742\u5fd7"},{"key":"10.1016\/j.micpath.2021.104915_bib26","first-page":"145","article-title":"Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center","volume":"10","author":"Husain","year":"2018","journal-title":"J. Lab. Phys."},{"key":"10.1016\/j.micpath.2021.104915_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13756-019-0545-z","article-title":"Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017)","volume":"8","author":"Tian","year":"2019","journal-title":"Antimicrob. Resist. Infect. Contr."},{"key":"10.1016\/j.micpath.2021.104915_bib28","first-page":"1187","article-title":"\u4e07\u53e4\u9709\u7d20\u548c\u5229\u5948\u5511\u80fa\u6cbb\u7597\u8010\u7532\u6c27\u897f\u6797\u91d1\u9ec4\u8272\u8461\u8404\u7403\u83cc\u6240\u81f4\u8179\u819c\u900f\u6790\u76f8\u5173\u6027\u8179\u819c\u708e\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\u6bd4\u8f83","volume":"46","year":"2018","journal-title":"\u4e2d\u56fd\u4e34\u5e8a\u533b\u751f\u6742\u5fd7."},{"key":"10.1016\/j.micpath.2021.104915_bib29","first-page":"45","article-title":"\u4e34\u5e8a\u836f\u5e08\u53c2\u4e0e\u8010\u7532\u6c27\u897f\u6797\u91d1\u9ec4\u8272\u8461\u8404\u7403\u83cc\u9aa8\u9ad3\u708e\u4f34\u80be\u529f\u80fd\u4ea2\u8fdb\u60a3\u513f\u7684\u6cbb\u7597\u5b9e\u8df5","volume":"27","author":"\u4f55\u7fe0\u7476","year":"2021","journal-title":"\u513f\u79d1\u836f\u5b66\u6742\u5fd7."},{"key":"10.1016\/j.micpath.2021.104915_bib30","first-page":"171+3","article-title":"\u66ff\u8003\u62c9\u5b81\u4e0e\u4e07\u53e4\u9709\u7d20\u6cbb\u7597\u80ba\u764c\u60a3\u8005\u8010\u7532\u6c27\u897f\u6797\u91d1\u9ec4\u8272\u8461\u8404\u7403\u83cc\u80ba\u708e\u7684\u6548\u679c\u89c2\u5bdf","volume":"7","author":"\u6768\u4e16\u754c","year":"2020","journal-title":"\u4e34\u5e8a\u533b\u836f\u6587\u732e\u7535\u5b50\u6742\u5fd7."},{"key":"10.1016\/j.micpath.2021.104915_bib31","doi-asserted-by":"crossref","unstructured":"Sarkar P, Haldar J. Glycopeptide Antibiotics Mechanism of Action and Recent Developments2020.","DOI":"10.1002\/9781119282549.ch4"},{"key":"10.1016\/j.micpath.2021.104915_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/IDR.S148335","article-title":"Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"11","author":"Lin","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2021.104915_bib33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2217\/17460913.3.5.547","article-title":"Acquired vancomycin resistance in clinically relevant pathogens","volume":"3","author":"Werner","year":"2008","journal-title":"Future Microbiol."},{"key":"10.1016\/j.micpath.2021.104915_bib34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/phar.1577","article-title":"Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus","volume":"35","author":"Gomes","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.micpath.2021.104915_bib35","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijantimicag.2016.02.003","article-title":"Transcriptional profiling of the two-component regulatory system VraSR in Staphylococcus aureus with low-level vancomycin resistance","volume":"47","author":"Chen","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2021.104915_bib36","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1139\/cjm-2016-0439","article-title":"Activated ADI pathway: the initiator of intermediate vancomycin resistance in Staphylococcus aureus","volume":"63","author":"Tan","year":"2017","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.micpath.2021.104915_bib37","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1128\/AAC.00420-16","article-title":"Complete reconstitution of the vancomycin-intermediate Staphylococcus aureus phenotype of strain Mu50 in vancomycin-susceptible S-aureus","volume":"60","author":"Katayama","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib38","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12275-013-3088-7","article-title":"Prevalence of amino acid changes in the yvqF, vraSR, graSR, and tcaRAB genes from vancomycin intermediate resistant Staphylococcus aureus","volume":"51","author":"Yoo","year":"2013","journal-title":"J. Microbiol."},{"key":"10.1016\/j.micpath.2021.104915_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jare.2019.10.005","article-title":"Vancomycin resistant Staphylococcus aureus infections: a review of case updating and clinical features","volume":"21","author":"Cong","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.micpath.2021.104915_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4161\/viru.21282","article-title":"Intrinsic and acquired resistance mechanisms in enterococcus","volume":"3","author":"Hollenbeck","year":"2012","journal-title":"Virulence"},{"key":"10.1016\/j.micpath.2021.104915_bib41","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.1090956","article-title":"Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus","volume":"302","author":"Weigel","year":"2003","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.micpath.2021.104915_bib42","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1128\/JCM.40.12.4659-4665.2002","article-title":"Characterization of Tn1546 in vancomycin-resistant Enterococcus faecium isolated from canine urinary tract infections: evidence of gene exchange between human and animal enterococci","volume":"40","author":"Simjee","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2021.104915_bib43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00128-016-1827-2","article-title":"VanA-type MRSA (VRSA) emerged in surface waters","volume":"97","author":"Icgen","year":"2016","journal-title":"Bull. Environ. Contam. Toxicol."},{"key":"10.1016\/j.micpath.2021.104915_bib44","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.15585\/mmwr.mm6437a2","article-title":"Unreported male sex partners among men with newly diagnosed HIV infection - North Carolina, 2011-2013","volume":"64","author":"Wu","year":"2015","journal-title":"Mmwr-Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.micpath.2021.104915_bib45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cbpa.2009.02.031","article-title":"Daptomycin: mechanisms of action and resistance, and biosynthetic engineering","volume":"13","author":"Baltz","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.micpath.2021.104915_bib46","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1128\/AAC.00738-06","article-title":"Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria","volume":"51","author":"Mortin","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/femsre\/fuv008","article-title":"Bacterial membrane lipids: diversity in structures and pathways","volume":"40","author":"Sohlenkamp","year":"2016","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.micpath.2021.104915_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijmm.2017.12.002","article-title":"Differential daptomycin resistance development in Staphylococcus aureus strains with active and mutated gra regulatory systems","volume":"308","author":"Mueller","year":"2018","journal-title":"International Journal of Medical Microbiology"},{"key":"10.1016\/j.micpath.2021.104915_bib49","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s10096-017-2999-3","article-title":"Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus","volume":"36","author":"Iwata","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2021.104915_bib50","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2958.2011.07576.x","article-title":"Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids","volume":"80","author":"Ernst","year":"2011","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.micpath.2021.104915_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067398","article-title":"Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates","volume":"8","author":"Bertsche","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104915_bib52","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2958.2010.07464.x","article-title":"A role for the essential YycG sensor histidine kinase in sensing cell division","volume":"79","author":"Fukushima","year":"2011","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.micpath.2021.104915_bib53","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1128\/JB.01936-06","article-title":"YycH and YycI interact to regulate the essential YycFG two-component system in Bacillus subtilis","volume":"189","author":"Szurmant","year":"2007","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2021.104915_bib54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1128\/AAC.00432-10","article-title":"VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus","volume":"56","author":"Mehta","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib55","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026997","article-title":"Mechanism of action and resistance to daptomycin in Staphylococcus aureus and enterococci","volume":"6","author":"Miller","year":"2016","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/j.micpath.2021.104915_bib56","doi-asserted-by":"crossref","first-page":"252","DOI":"10.12688\/f1000research.5512.1","article-title":"Diversity of two-component systems: insights into the signal transduction mechanism by the Staphylococcus aureus two-component system GraSR","volume":"3","author":"Muzamal","year":"2014","journal-title":"F1000Research."},{"key":"10.1016\/j.micpath.2021.104915_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002359","article-title":"Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR","volume":"7","author":"Howden","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2021.104915_bib58","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1128\/AAC.01303-15","article-title":"Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene","volume":"59","author":"Baek","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028316","article-title":"Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus","volume":"7","author":"Peleg","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104915_bib60","doi-asserted-by":"crossref","first-page":"16808","DOI":"10.1073\/pnas.1300118110","article-title":"How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function","volume":"110","author":"Otero","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.micpath.2021.104915_bib61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jgar.2019.02.018","article-title":"Bactericidal activity of ceftaroline, vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus isolates from cancer patients","volume":"17","author":"Rolston","year":"2019","journal-title":"Journal of Global Antimicrobial Resistance"},{"key":"10.1016\/j.micpath.2021.104915_bib62","doi-asserted-by":"crossref","DOI":"10.1177\/2309499019850324","article-title":"Addition of ceftaroline fosamil or vancomycin to PMMA: an in vitro comparison of biomechanical properties and anti-MRSA efficacy","volume":"27","author":"Haseeb","year":"2019","journal-title":"J. Orthop. Surg."},{"key":"10.1016\/j.micpath.2021.104915_bib63","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/AAC.04068-14","article-title":"Missense mutations in PBP2A affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in western Switzerland archived since 1998","volume":"59","author":"Kelley","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00485-18","article-title":"Ceftaroline resistance by clone-specific polymorphism in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus","volume":"62","author":"Lee","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib65","doi-asserted-by":"crossref","first-page":"114852","DOI":"10.1016\/j.diagmicrobio.2019.06.004","article-title":"Genotypic analysis of Italian MRSA strains exhibiting low-level ceftaroline and ceftobiprole resistance","volume":"95","author":"Bongiorno","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2021.104915_bib66","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1093\/jac\/dkv131","article-title":"Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline","volume":"70","author":"Lahiri","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib67","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1128\/AAC.00358-16","article-title":"PBP 4 mediates high-level resistance to new-generation cephalosporins in Staphylococcus aureus","volume":"60","author":"Chan","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib68","first-page":"61","article-title":"High-level resistance of Staphylococcus aureus to beta-lactam antibiotics mediated by penicillin-binding protein 4 (PBP4)","author":"Hamilton","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib69","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1089\/mdr.2019.0130","article-title":"In vitro ceftaroline resistance selection of methicillin-resistant Staphylococcus aureus involves different genetic pathways","volume":"25","author":"Gostev","year":"2019","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.micpath.2021.104915_bib70","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10096-016-2807-5","article-title":"Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals","volume":"36","author":"Andrey","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2021.104915_bib71","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/jac\/dkv329","article-title":"Potential of Staphylococcus aureus isolates carrying different PBP2a alleles to develop resistance to ceftaroline","volume":"71","author":"Lahiri","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib72","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/jac\/dku114","article-title":"Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective","volume":"69","author":"Alm","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149541","article-title":"Whole-genome sequencing of methicillin-resistant Staphylococcus aureus resistant to fifth-generation cephalosporins reveals potential non-mecA mechanisms of resistance","volume":"11","author":"Greninger","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104915_bib74","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/AAC.02333-15","article-title":"The Staphylococcus aureus chaperone PrsA is a new auxiliary factor of oxacillin resistance affecting penicillin-binding protein 2A","volume":"60","author":"Jousselin","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib75","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1021\/jm800038g","article-title":"Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections","volume":"51","author":"Brickner","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micpath.2021.104915_bib76","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.plasmid.2018.09.011","article-title":"Linezolid resistance genes and genetic elements enhancing their dissemination in enterococci and streptococci","volume":"99","author":"Sadowy","year":"2018","journal-title":"Plasmid"},{"key":"10.1016\/j.micpath.2021.104915_bib77","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/CEOR.S91985","article-title":"Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic","volume":"8","author":"Lesher","year":"2016","journal-title":"Clin. Outcomes Res."},{"key":"10.1016\/j.micpath.2021.104915_bib78","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/AAC.42.12.3251","article-title":"The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria","volume":"42","author":"Swaney","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib79","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/AAC.05702-11","article-title":"Resistance to linezolid caused by modifications at its binding site on the ribosome","volume":"56","author":"Long","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib80","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/AAC.01308-10","article-title":"Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in cleveland","volume":"55","author":"Endimiani","year":"2011","journal-title":"Ohio. Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.micpath.2021.104915_bib81","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1128\/AAC.01098-07","article-title":"Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances","volume":"52","author":"Besier","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3343\/alm.2020.40.1.57","article-title":"Linezolid resistance in methicillin-resistant Staphylococcus aureus in korea: high rate of false resistance to linezolid by the VITEK 2 system","volume":"40","author":"Yoo","year":"2020","journal-title":"Annals of Laboratory Medicine"},{"key":"10.1016\/j.micpath.2021.104915_bib83","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1128\/AAC.00714-10","article-title":"Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with Co-occurring mutations in ribosomal protein L3","volume":"54","author":"Locke","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib84","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1128\/AAC.00871-09","article-title":"Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700)","volume":"53","author":"Locke","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib85","article-title":"Mechanisms of linezolid resistance among clinical Staphylococcus spp. in Spain: spread of methicillin- and linezolid-resistant S. Epidermidis ST2","author":"Ruiz-Ripa","year":"2020","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.micpath.2021.104915_bib86","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2147\/DDDT.S164515","article-title":"Linezolid: a review of its properties, function, and use in critical care","volume":"12","author":"Hashemian","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.micpath.2021.104915_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.02925","article-title":"Characterization of the multi-drug resistance gene cfr in methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from animals and humans in China","volume":"9","author":"Li","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2021.104915_bib88","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1093\/jac\/dky129","article-title":"Increased activity of linezolid in combination with rifampicin in a murine pneumonia model due to MRSA","volume":"73","author":"Zhou","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2021.104915_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.03080","article-title":"Linezolid and rifampicin combination to combat cfr-positive multidrug-resistant MRSA in murine models of bacteremia and skin and skin structure infection","volume":"10","author":"Zhou","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2021.104915_bib90","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1093\/jac\/dkx292","article-title":"Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE","volume":"72","author":"Lazaris","year":"2017","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102100187X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102100187X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:33:06Z","timestamp":1760110386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088240102100187X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":90,"alternative-id":["S088240102100187X"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104915","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104915"}}